CardioComm Solutions, Inc: Cardiologists to Use the HeartCheck CardiBeat With ECG Triaging Services for Remote Patient ECG Monitoring
TORONTO, ON / ACCESSWIRE / December 20, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) (
CardioComm or the
Company ), a global provider of consumer heart monitoring and electrocardiogram (
ECG ) device and software solutions, confirms the start of an out-of-office ECG monitoring program using the HeartCheck CardiBeat Handheld ECG monitor, the GEMS Mobile RPM Smartphone app and the SMART Monitoring ECG triaging service to support prescribed in-home arrhythmia monitoring.
The Heart Health Institute (
HHI ), a large arrhythmia practice network located in the Greater Toronto Area (Ontario, Canada), will be recommending the HeartCheck CardiBeat to their cardiac patients for up to six months of in-home, arrhythmia self-monitoring use with an emphasis on detecting a recurrence of atrial fibrillation and supraventricular tachycardia.
Quebec Pharmacists Launch ECG Screening for the Prevention of Drug Induced Sudden Cardiac Death
albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.
Quebec Pharmacists Launch ECG Screening for the Prevention of Drug Induced Sudden Cardiac Death - Press Release
digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.
CardioComm Solutions, Inc: Quebec Pharmacists Launch ECG Screening for the Prevention of Drug Induced Sudden Cardiac Death
TORONTO, ON / ACCESSWIRE / December 17, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) (
CardioComm or the
Company ), a global provider of consumer heart monitoring and electrocardiogram (
ECG ) device and software solutions, confirms the start of a pharmacy-based ECG monitoring service to screen for prolonged QT interval for the prevention of drug induced sudden cardiac death.
Under the Company s Allied Health Professional Partner Program, the HeartCheck CardiBeat and GEMS Mobile Smartphone app will be used to collect ECGs recorded by patients under the direction of a pharmacist. Recorded ECGs will be passed from the GEMS Mobile app to the Company s SMART Monitoring ECG reading service to be triaged. All findings will be sent directly to the pharmacist and any submitted ECG recordings that show a presence of prolonged QT interval or any other cardiac arr